{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:53:39Z","timestamp":1774126419607,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early beta-blocker treatment has long been recommended for patients with acute myocardial infarction (AMI), particularly when left ventricular ejection fraction (LVEF) is reduced; however, whether beta-blocker therapy improves outcomes in patients with AMI receiving contemporary treatment remains uncertain. This study aimed to investigate temporal trends in the effect of beta-blocker therapy on outcomes of patients with AMI in a large, nationwide cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with AMI enrolled in the Acute Coronary Syndromes Israeli Survey from 2000 to 2021 were included. They were categorized into three periods: early (2000\u20132004), mid (2006\u20132016), and late (2018\u20132021). Each period group was further divided into two subgroups based on LVEF (&gt;40 and \u226440%) and then stratified by beta-blocker treatment status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort consisted of 11 569 patients. Among patients with LVEF less than 40%, beta-blocker treatment was associated with improved 1-year survival rates in the early (9.1 vs. 20.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and mid (10 vs. 20.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) periods only. Among patients with LVEF greater than or equal to 40%, beta-blocker treatment was linked to enhanced 1-year survival in patients enrolled in the early period (3.4 vs. 7.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), but not in the mid and late periods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The association between beta-blocker treatment and improved survival in patients with AMI has diminished over recent decades, regardless of LVEF. These findings are likely attributed to the advancements in contemporary medical and revascularization therapy. As such, our results may challenge current recommendations regarding beta-blocker therapy in AMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001568","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:02:08Z","timestamp":1755795728000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Temporal trends in the treatment with beta-blocker and the effect on outcome of patients with acute myocardial infarction"],"prefix":"10.1097","volume":"37","author":[{"given":"Ela","family":"Giladi","sequence":"first","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Losin","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Arow","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranin","family":"Hilu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oded","family":"Sabah","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sheba Medical Center, Ramat Gan, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Barashi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Omelchenko","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Arnson","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abid","family":"Assali","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pereg","sequence":"additional","affiliation":[{"name":"Cardiology Department, Meir Medical Center, Kfar-Saba"},{"name":"Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"R1-20260130","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"\u03b2 Blockade after myocardial infarction: systematic review and meta regression analysis.","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"R2-20260130","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial.","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"R3-20260130","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/eurheartj\/ehaa376","article-title":"Long-term \u03b2-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"key":"R4-20260130","doi-asserted-by":"crossref","first-page":"P3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC).","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R5-20260130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","article-title":"Long-term use of cardiovascular drugs: challenges for research and for patient care.","volume":"66","author":"Rossello","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.recesp.2014.07.029","article-title":"Prognostic benefit of beta-blockers after acute coronary syndrome with preserved systolic function. Still relevant today?","volume":"68","author":"Raposeiras-Roub\u00edn","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R7-20260130","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"\u03b2-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction.","volume":"69","author":"Dondo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R8-20260130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9343(83)91127-0","article-title":"Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.","volume":"74","author":"Braunwald","year":"1983","journal-title":"Am J Med"},{"key":"R9-20260130","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijcard.2012.10.050","article-title":"Early intravenous beta-blockers in patients with acute coronary syndrome \u2013 a meta-analysis of randomized trials.","volume":"168","author":"Chatterjee","year":"2013","journal-title":"Int J Cardiol"},{"key":"R10-20260130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials.","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"R11-20260130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199303113281001","article-title":"A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction.","volume":"328","author":"Grines","year":"1993","journal-title":"N Engl J Med"},{"key":"R12-20260130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199706053362301","article-title":"A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"R13-20260130","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-20260130","doi-asserted-by":"crossref","first-page":"e0199347","DOI":"10.1371\/journal.pone.0199347","article-title":"Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.","volume":"13","author":"Watanabe","year":"2018","journal-title":"PLoS One"},{"key":"R15-20260130","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"R16-20260130","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction.","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"key":"R17-20260130","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2404204","article-title":"Beta-blocker interruption or continuation after myocardial infarction.","volume":"391","author":"Silvain","year":"2024","journal-title":"N Engl J Med"},{"key":"R18-20260130","doi-asserted-by":"crossref","first-page":"101582","DOI":"10.1016\/j.jacadv.2024.101582","article-title":"Beta-blocker therapy after myocardial infarction.","volume":"4","author":"Miranda","year":"2025","journal-title":"JACC Adv"},{"key":"R19-20260130","first-page":"CD012484","article-title":"Beta-blockers for suspected or diagnosed acute myocardial infarction.","volume":"12","author":"Safi","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20260130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.101.5.558","article-title":"\u03b2-adrenergic receptor blockade in chronic heart failure.","volume":"101","author":"Bristow","year":"2000","journal-title":"Circulation"},{"key":"R21-20260130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0002-9149(99)00873-5","article-title":"Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty.","volume":"85","author":"Bonnemeier","year":"2000","journal-title":"Am J Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:00:51Z","timestamp":1769774451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001568","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"2025-03-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}